KJCO :: Korean Journal of Clinical Oncology

REVIEW 2025 April 30 Metastasis-associated protein 1: a druggable target in cancer treatment
Cancer treatment has undergone significant transformation with the emergence of molecularly targeted drugs, aiming to exploit specific vulnerabilities within cancer cells while sparing normal tissues. One critical aspect of this approach is the identification of druggable target...

ORIGINAL ARTICLE 2025 January 3 Prognostic significance of tumor budding in endometrial cancer: clinicopathological insights
Purpose: Endometrial cancer is one of the most common gynecological cancers worldwide, with rising incidence rates. Despite therapeutic advances, it remains a significant cause of cancer-related deaths. Tumor budding (TB), characterized by single cells or small clusters at the i...

ORIGINAL ARTICLE 2025 April 30 Tumor budding in invasive breast carcinoma and its association with clinicopathological parameters: an experience from a tertiary care center in India
Purpose: Breast cancer is one of the most common cancers globally, with an increasing incidence rate. It is a heterogeneous disease, and early metastasis remains a challenge. Tumor budding, defined as single tumor cells or small clusters at the invasive front, has been suggested...